Clinical utility of dual-energy CT for evaluation of tophaceous gout

Radiographics

Volumn 31, Issue 5, 2011, Pages 1365-1375

  Desai, Madhura A ^a   Peterson, Jeffrey J ^a   Garner, Hillary Warren ^a   Kransdorf, Mark J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ARTHRITIS; ARTICLE; CALCINOSIS; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CRYSTALLIZATION; DIFFERENTIAL DIAGNOSIS; EQUIPMENT DESIGN; FOOT MALFORMATION; GOUT; HAND MALFORMATION; HUMAN; HYPERURICEMIA; METABOLISM; METHODOLOGY; OSTEOMYELITIS; RADIOGRAPHY; SYNOVIAL FLUID; TENDINITIS;

ARTHRITIS; ARTHRITIS, GOUTY; CALCINOSIS; CRYSTALLIZATION; DIAGNOSIS, DIFFERENTIAL; EQUIPMENT DESIGN; FOOT DEFORMITIES, ACQUIRED; HAND DEFORMITIES, ACQUIRED; HUMANS; HYPERURICEMIA; OSTEOMYELITIS; SYNOVIAL FLUID; TENDINOPATHY; TOMOGRAPHY, X-RAY COMPUTED; URIC ACID;

EID: 80052875342     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.315115510     Document Type: Article

References (38)

1. Richette P, Bardin T. Gout. Lancet 2010;375(9711):318-328.
2. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58(1):26-35.
3. Ning TC, Keenan RT. Unusual clinical presentations of gout. Curr Opin Rheumatol 2010;22(2):181-187.
4. Coursey CA, Nelson RC, Boll DT, et al. Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging? RadioGraphics 2010;30(4):1037-1055.
5. Karcaaltincaba M, Aktas A. Dual-energy CT revisited with multidetector CT: review of principles and clinical applications. Diagn Interv Radiol 2010 Nov 14. [Epub ahead of print]
6. Primak AN, Fletcher JG, Vrtiska TJ, et al. Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol 2007;14(12):1441-1447.
7. Graser A, Johnson TR, Bader M, et al. Dual energy CT characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol 2008;43(2):112-119.
8. Ascenti G, Siragusa C, Racchiusa S, et al. Stone-targeted dual-energy CT: a new diagnostic approach to urinary calculosis. AJR Am J Roentgenol 2010;195(4):953-958.
9. Stolzmann P, Kozomara M, Chuck N, et al. In vivo identification of uric acid stones with dual-energy CT: diagnostic performance evaluation in patients. Abdom Imaging 2010;35(5):629-635.
10. Hidas G, Eliahou R, Duvdevani M, et al. Determination of renal stone composition with dual-energy CT: in vivo analysis and comparison with x-ray diffraction. Radiology 2010;257(2):394-401.
11. Schlesinger N. Diagnosis of gout: clinical, laboratory, and radiologic findings. Am J Manag Care 2005;11(15 Suppl):S443-S450; quiz S465-S468.
12. Chen LX, Schumacher HR. Gout: can we create an evidence-based systematic approach to diagnosis and management? Best Pract Res Clin Rheumatol 2006;20(4):673-684.
13. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20(3):895-900.
14. Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I. Diagnosis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65(10):1301-1311.
15. Johnson TR, Weckbach S, Kellner H, Reiser MF, Becker CR. Clinical image: Dual-energy computed tomographic molecular imaging of gout. Arthritis Rheum 2007;56(8):2809.
16. McCarty DJ. Gout without hyperuricemia. JAMA 1994;271(4):302-303.
17. Logan JA, Morrison E, McGill PE. Serum uric acid in acute gout. Ann Rheum Dis 1997;56(11):696-697.
18. Schlesinger N, Baker DG, Schumacher HR Jr. Serum urate during bouts of acute gouty arthritis. J Rheumatol 1997;24(11):2265-2266.
19. Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther 2010;12(6):223.
20. Nicolaou S, Yong-Hing CJ, Galea-Soler S, Hou DJ, Louis L, Munk P. Dual-energy CT as a potential new diagnostic tool in the management of gout in the acute setting. AJR Am J Roentgenol 2010;194(4):1072-1078.
21. Buckley TJ. Radiologic features of gout. Am Fam Physician 1996;54(4):1232-1238.
22. Agudelo CA, Weinberger A, Schumacher HR, Turner R, Molina J. Definitive diagnosis of gout by identification of urate crystals in asymptomatic metatarsophalangeal joints. Arthritis Rheum 1979;22(5):559-560.
23. Bomalaski JS, Lluberas G, Schumacher HR Jr. Monosodium urate crystals in the knee joints of patients with asymptomatic nontophaceous gout. Arthritis Rheum 1986;29(12):1480-1484.
24. Choi HK, Al-Arfaj AM, Eftekhari A, et al. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis 2009;68(10):1609-1612.
25. Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118(8):816-826.
26. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007;116(8):894-900.
27. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008;359(17):1811-1821.
28. Krishnan E. Gout and coronary artery disease: epidemiologic clues. Curr Rheumatol Rep 2008;10(3):249-255.
29. Puig JG, Martínez MA. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 2008;20(2):187-191.
30. Dao HH, Harun-Or-Rashid M, Sakamoto J. Body composition and metabolic syndrome in patients with primary gout in Vietnam. Rheumatology (Oxford) 2010;49(12):2400-2407.
31. Sack K. Monarthritis: differential diagnosis. Am J Med 1997;102(1A):30S-34S.
32. Grainger R, Taylor WJ, Dalbeth N, et al. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol 2009;36(10):2346-2355.
33. Dalbeth N, Schauer C, Macdonald P, et al. Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Ann Rheum Dis 2011;70(4):597-604.
34. Dalbeth N, Clark B, Gregory K, Gamble GD, Doyle A, McQueen FM. Computed tomography measurement of tophus volume: comparison with physical measurement. Arthritis Rheum 2007;57(3):461-465.
35. Schumacher HR Jr, Becker MA, Edwards NL, et al. Magnetic resonance imaging in the quantitative assessment of gouty tophi. Int J Clin Pract 2006;60(4):408-414.
36. Popp JD, Bidgood WD Jr, Edwards NL. Magnetic resonance imaging of tophaceous gout in the hands and wrists. Semin Arthritis Rheum 1996;25(4):282-289.
37. Thiele RG. Role of ultrasound and other advanced imaging in the diagnosis and management of gout. Curr Rheumatol Rep 2011;13(2):146-153.
38. Bacani AK, McCollough CH, Glazebrook KN, et al. Dual energy computed tomography for quantification of tissue urate deposits in tophaceous gout: help from modern physics in the management of an ancient disease. Rheumatol Int 2009 Dec 17. [Epub ahead of print]